Search

Search Constraints

You searched for: Author/Creator Nantz, E.

Search Results

1. SAT0005 Human C-Type Lectin Domain Family 4, Member C Gene Expression Level Helps Predict Future Clinical Response to Tabalumab Blockade of Baff in Rheumatoid Arthritis. (23rd January 2014)

2. THU0175 Effects of Baricitinib on Multibiomarker Disease Activity Scores and Their Components in a Phase 2B Study in Moderate-to-Severe Rheumatoid Arthritis Patients. (9th June 2015)

3. Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation. Issue 4 (18th January 2016)

4. THU0201 Weak Correlation between A Multi-Biomarker Disease Activity Score and Clinical Response with Baricitinib in A Phase 2b Study in Rheumatoid Arthritis. (15th July 2016)

5. OP0079 Pharmacodynamic Changes in Gene Expression Observed in Two Phase 3 Trials of Baff Blockade with Tabalumab in SLE. (9th June 2015)